Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide for Cerebral Edema After Endovascular Treatment in Acute Ischemic Stroke
NCT07528456Phase 4Not yet recruiting
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Apr 2026
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of butylphthalide in ischemic stroke, cerebral edema, sponsored by Nanfang Hospital, Southern Medical University. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
butylphthalide
03
Conditions
ischemic strokecerebral edema
Beyond the preview
Go deeper on NCT07528456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07528456.